MRK vs NVO
Merck & Co. vs Novo Nordisk A/S — AI-powered side-by-side comparison
| Metric | MRK | NVO |
|---|---|---|
| AI Score | 56 | 53 |
| Price | $125.97 | $48.90 |
| P/E Ratio | 35.46× | 11.67× |
| ROE | 17.9% | 66.4% |
| Revenue Growth YoY | 2.9% | 8.1% |
| Gross Margin | 78.1% | 81.8% |
| Debt / Equity | 0.94× | 0.67× |
| Dividend Yield | 2.6% | 3.6% |
| RSI (14) | 54.6 | 63.6 |
| Beta | 0.2095 | 1.8569 |
| Expected Upside | — | +26.8% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
MRK Full Analysis
NVO Full Analysis